FDA.reportPublic FDA data

ziprasidone hydrochloride anhydrous

RxCUI
1362139
RxNorm name
ziprasidone hydrochloride anhydrous
Term type
PIN
Status
Active
Updated
2026-10-06 01:47:19

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
012013
Active start
012013
Multiple ingredient
NO
Branded
NO

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
ziprasidone115698

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
RXNAV_STRziprasidone hydrochloride anhydrous1NAMES
RxNorm Nameziprasidone hydrochloride anhydrous1NAMES
TTYPIN1ATTRIBUTES
RxCUI13621391CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN05AEIndole derivativesATC1-4ziprasidone
FDASPLN0000175430Atypical AntipsychoticEPChas_epcziprasidone
MEDRTD010879PiperazinesCHEMhas_ingredientziprasidone
MEDRTD013844ThiazolesCHEMhas_ingredientziprasidone
MEDRTD001145Arrhythmias, CardiacDISEASEci_withziprasidone
MEDRTD001145Arrhythmias, CardiacDISEASEci_withziprasidone hydrochloride anhydrous
MEDRTD004342Drug HypersensitivityDISEASEci_withziprasidone
MEDRTD004342Drug HypersensitivityDISEASEci_withziprasidone hydrochloride anhydrous
MEDRTD006333Heart FailureDISEASEci_withziprasidone
MEDRTD006333Heart FailureDISEASEci_withziprasidone hydrochloride anhydrous
MEDRTD009203Myocardial InfarctionDISEASEci_withziprasidone
MEDRTD009203Myocardial InfarctionDISEASEci_withziprasidone hydrochloride anhydrous
MEDRTD012559SchizophreniaDISEASEmay_treatziprasidone
MEDRTD012559SchizophreniaDISEASEmay_treatziprasidone hydrochloride anhydrous
MEDRTD005879Tourette SyndromeDISEASEmay_treatziprasidone
MEDRTD005879Tourette SyndromeDISEASEmay_treatziprasidone hydrochloride anhydrous
MEDRTN0000000099Adrenergic alpha-AntagonistsMOAhas_moaziprasidone
MEDRTN0000000099Adrenergic alpha-AntagonistsMOAhas_moaziprasidone hydrochloride anhydrous
MEDRTN0000000230Dopamine AntagonistsMOAhas_moaziprasidone
MEDRTN0000000230Dopamine AntagonistsMOAhas_moaziprasidone hydrochloride anhydrous
MEDRTN0000000190Histamine H1 Receptor AntagonistsMOAhas_moaziprasidone
MEDRTN0000000190Histamine H1 Receptor AntagonistsMOAhas_moaziprasidone hydrochloride anhydrous
MEDRTN0000000130Serotonin AntagonistsMOAhas_moaziprasidone
MEDRTN0000000130Serotonin AntagonistsMOAhas_moaziprasidone hydrochloride anhydrous
MEDRTN0000008588Decreased Dopamine ActivityPEhas_peziprasidone
MEDRTN0000008588Decreased Dopamine ActivityPEhas_peziprasidone hydrochloride anhydrous
MEDRTN0000008657Decreased Histamine ActivityPEhas_peziprasidone
MEDRTN0000008657Decreased Histamine ActivityPEhas_peziprasidone hydrochloride anhydrous
MEDRTN0000008764Decreased Norepinephrine ActivityPEhas_peziprasidone
MEDRTN0000008764Decreased Norepinephrine ActivityPEhas_peziprasidone hydrochloride anhydrous
MEDRTN0000008893Decreased Serotonin ActivityPEhas_peziprasidone
MEDRTN0000008893Decreased Serotonin ActivityPEhas_peziprasidone hydrochloride anhydrous

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYSINGLE
CODESSNOMEDCT1269085001
SOURCESSourceUS Edition of SNOMED_CT